Vitamin B12 (Methylcobalamin)
SupplementThe small divergence reflects broad agreement between clinical evidence [s7, s9] and user experiences [c1, c2]. The community rates subjectively perceived improvements in energy and cognition more highly than is justified by clinical endpoints (particularly nerve conduction velocity).
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
For confirmed B12 deficiency, methylcobalamin is one of the most effective and safest interventions available — meta-analyses show clear benefits for peripheral neuropathy, and high-dose oral supplementation performs comparably to injections. The community's strong preference for methylcobalamin over cyanocobalamin is understandable, but scientific superiority over hydroxocobalamin is not well established. Without a deficiency, expect little to no effect. Store away from light; contraindicated in LHON and polycythaemia vera.
Description
Bioactive form of vitamin B12; directly utilizable without conversion in the body. Supports nerve function, methylation metabolism, and homocysteine degradation [s1, s2].
Methylcobalamin (MeCbl) is one of the two bioactive coenzyme forms of vitamin B12 (alongside adenosylcobalamin) and occurs naturally in animal foods, particularly in dairy products [s1]. Unlike the synthetic form cyanocobalamin, methylcobalamin does not require conversion into an active form in the body; it is directly available to metabolism [s2, s3]. Vitamin B12 deficiency affects up to 40% of the Western population at a subclinical level (serum levels 200–300 pg/mL) and is particularly prevalent in vegans, vegetarians, older adults, and individuals with malabsorption disorders (Crohn's disease, celiac disease, Helicobacter pylori infection, metformin use, proton pump inhibitors) [s5, s6]. The most clinically relevant indications are: treatment and prevention of B12 deficiency anemia, peripheral neuropathy (particularly diabetic neuropathy), homocysteine reduction, and support of nerve function and cognitive processes [s4, s7, s8]. For vegans and other at-risk groups, the DGE recommends regular monitoring of B12 blood levels [s13]. According to a recent meta-analysis, methylcobalamin demonstrates comparable efficacy to intramuscular injections when administered sublingually or orally at sufficiently high doses [s9].
Legal Status (DE)
In Germany, methylcobalamin is marketable as an over-the-counter dietary supplement. No approved finished medicinal product containing methylcobalamin exists in Germany; however, cyanocobalamin and hydroxocobalamin injection preparations are available as prescription-only medicines [s11, s12].
Mechanism of Action
Methylcobalamin acts as a cofactor for the enzyme methionine synthase (5-methyltetrahydrofolate- homocysteine methyltransferase, MTR) in the cytoplasm of cells. This enzyme catalyzes the remethylation of homocysteine to methionine via transfer of a methyl group from 5-methyltetrahydrofolate (5-MTHF) [s1, s2]. Methionine is subsequently converted to S-adenosylmethionine (SAM), the central methyl group donor for numerous biological methylation reactions (DNA methylation, neurotransmitter synthesis, myelin synthesis) [s2]. Adenosylcobalamin — the mitochondrial counterpart — is a cofactor of methylmalonyl-CoA mutase, which isomerizes methylmalonyl-CoA to succinyl-CoA, an intermediate in fatty acid and amino acid metabolism [s1, s2]. With insufficient B12 availability, homocysteine accumulates in the blood, which is associated with increased cardiovascular risk and nerve damage [s5]. Additionally, methylcobalamin is involved in myelin synthesis, which explains its therapeutic relevance in peripheral neuropathy [s4, s7]. Methylcobalamin also modulates circadian rhythms: it enhances the phase shift of the melatonin rhythm, which may explain its influence on sleep-wake cycles [s10].
Dosing
Prävention B12-Mangel (Veganer, Vegetarier)
- Dose
- 10 µg daily OR 1,000–2,000 µg 1–2× per week
- Frequency
- täglich oder 1–2× wöchentlich
- Route
- oral
- Duration
- fortlaufend
- Timing
- Any time, preferably in the morning
- With food
- optional
Behandlung manifester B12-Mangel (oral)
- Dose
- 1,000–2,000 µg daily
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 3–6 Monate, dann Erhaltungsdosis
- Timing
- In the morning on an empty stomach or sublingually for better absorption
- With food
- optional
Periphere Neuropathie (diabetisch)
- Dose
- 500 µg 3× daily (oral) or intramuscularly as prescribed by a physician
- Frequency
- 3× täglich
- Route
- oral
- Duration
- mindestens 12 Wochen
- Timing
- With meals
- With food
- empfohlen
Sublingual-Supplementierung (allgemein)
- Dose
- 1,000 µg sublingually daily
- Frequency
- 1× täglich
- Route
- sublingual
- Duration
- fortlaufend
- Timing
- In the morning, allow tablet to dissolve under the tongue
- With food
- vermeiden
EFSA and BfR have not established a Tolerable Upper Intake Level (UL) for vitamin B12, as no toxic effects have been observed with oral intake even at very high amounts. Nevertheless, the BfR proposes maximum levels for dietary supplements based on physiological requirement values [s15].
Methylcobalamin is light-sensitive and should be stored protected from light. In cases of MTHFR polymorphism, methylcobalamin is preferred over cyanocobalamin, as no conversion is required [s3].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Übelkeit, Bauchschmerzen, Durchfall Gastrointestinal complaints with oral ingestion of high doses, documented as an adverse effect in clinical trials [s4]. | gelegentlich | leicht |
| Kopfschmerzen Reported in clinical studies and case reports with methylcobalamin supplementation [s4]. | gelegentlich | leicht |
| Akne oder Hautausschlag Occasionally described with high-dose cobalamin supplementation; mechanism unclear [s5]. | selten | leicht |
| Paradoxe Verschlechterung des Gehirnnebels bei hohen Dosen Described in community reports, possibly due to overstimulation of the methylation cycle in MTHFR polymorphism or folate imbalance [c2]. | selten | leicht |
| Hypokaliämie (bei parenteraler Hochdosistherapie) During rapid treatment of severe megaloblastic anemia, erythropoiesis stimulation can shift potassium into cells [s5]. | selten | moderat |
Contraindications
Cyanocobalamin is contraindicated in LHON; methylcobalamin is considered a safer alternative, but caution is warranted here as well [s5].
Allergic reactions to cobalamin preparations are rare but have been reported [s5].
High-dose B12 administration may exacerbate existing hematological disorders with uncontrolled cell proliferation [s5].
Interactions
Synergistic
Methylcobalamin and folic acid act jointly in the methylation cycle; combined administration lowers homocysteine more effectively than monotherapy [s2, s8].
B6, B9, and B12 together synergistically lower homocysteine; a common combination in B-complex supplements [s8].
Methylcobalamin covers cytosolic, adenosylcobalamin mitochondrial B12 functions; combination recommended for complete cofactor replacement [s3].
Caution
Metformin inhibits B12 absorption; patients on long-term metformin therapy have an increased risk of deficiency and should have B12 levels monitored [s6].
Long-term use reduces gastric acid, thereby impairing B12 release from dietary proteins [s6].
May diminish the hematopoietic response to B12 [s5].
Nitrous oxide irreversibly oxidizes cobalamin and inactivates methionine synthase; can trigger acute functional B12 deficiency [s5, c2].
Studies
Tier A — High Evidence
Outcome: Comparison of sublingual/oral vs. intramuscular: serum B12 levels, homocysteine
Effect Size: No significant superiority of i.m. route over sublingual/oral at adequate doses
Outcome: Clinical efficacy, pain score, neuropathic symptoms, nerve conduction velocity in peripheral neuropathy
Effect Size: Mecobalamin alone superior to control for clinical efficacy; not significant for NCV and pain score
Outcome: Cognitive function, depressive symptoms, fatigue with vitamin B12 supplementation
Effect Size: Inconsistent results; significant improvement primarily in manifestly deficient populations
Tier B — Moderate Evidence
Outcome: Comparison of bioavailability and utilization of different B12 forms
Effect Size: Methylcobalamin, adenosylcobalamin, and hydroxocobalamin are bioidentical; cyanocobalamin is synthetic
Outcome: Effects of methyl- and cyanocobalamin on circadian rhythm, well-being, and alertness
Effect Size: Preliminary evidence for an influence of methylcobalamin on melatonin phase shifting
Tier C — Low Evidence
Outcome: High-dose methylcobalamin (500 µg/kg) and motoneuron regeneration in B12 neuropathy animal model
Effect Size: Significant motoneuron regeneration in animal model; limited clinical transferability
Community Evidence
Top reported benefits
- Marked reduction in fatigue and brain fog
- Improvement of neurological symptoms (tingling, numbness)
- Preference for methylcobalamin over cyanocobalamin due to direct bioavailability
- Mood elevation and improved concentration
- Rapid effect in confirmed B12 deficiency (sometimes within days)
Top reported issues
- Headaches and worsening brain fog at very high doses
- Paradoxical reactions in MTHFR polymorphism without concurrent folate supplementation
- Preparation stability (light sensitivity) as a quality issue
- No noticeable effect in users with already adequate B12 levels
Some users report adverse effects from nitrous oxide consumption in combination with B12 deficiency [c2]. Community preference for methylcobalamin is strongly pronounced, but scientific evidence for superiority over hydroxocobalamin for most indications is limited [s3]. Overdosing is frequently regarded as uncritical by the community, which may be problematic in niche indications (LHON, polycythaemia vera) [s5].
Scientific Sources
- Methylcobalamin - Wikipedia
Wikipedia contributors (2024). WikipediaCLink - Effects of vitamin B12 on performance and circadian rhythm in normal subjects
Mayer G, Kroger M, Meier-Ewert K (1996). NeuropsychopharmacologyBPMID:8914118DOI - Vitamin B12 - Hydroxocobalamin, Cyanocobalamin or Methylcobalamin - German Mail Order Pharmacy
arzneiprivat.de editorial (2023). arzneiprivat.deCLink - Stoffe in Nahrungsergänzungsmitteln: Was ist erlaubt? Was ist verboten?
Verbraucherzentrale Deutschland (2023). Verbraucherzentrale.deBLink - Ausgewählte Fragen und Antworten zu Vitamin B₁₂ | DGE
Deutsche Gesellschaft für Ernährung (DGE) (2023). DGEALink - Vitamin B12 bei veganer Ernährung: Leitfaden zu Versorgung, Dosierung und Blutwerten
vegpool.de editorial (2023). vegpool.deCLink - Höchstmengen für Vitamin B12 in Lebensmitteln inklusive Nahrungsergänzungsmitteln
Bundesinstitut für Risikobewertung (BfR) (2021). BfRALink - Vitamin B12 - Wikipedia
Wikipedia contributors (2024). WikipediaCLink - Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements With Potential to Mitigate B12-related Genetic Polymorphisms
Thiel RJ, Fowkes SW (2017). Journal of Orthomolecular Medicine (PMC5312744)BLink - Verwendung, Nutzen und Dosierung von Methylcobalamin
Drugslib editorial (2023). Drugslib.comCLink - Vitamin B12 - Health Professional Fact Sheet
National Institutes of Health, Office of Dietary Supplements (2024). NIH Office of Dietary SupplementsALink - Vitamin B12 Deficiency: Recognition and Management
Langan RC, Goodbred AJ (2017). American Family PhysicianBPMID:28925645 - Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Li S, Li Q, Li Y, et al. (2020). Journal of Alternative and Complementary MedicineAPMID:32716261DOI - Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression
Markun S, Gravestock I, Jäger L, et al. (2021). NutrientsAPMID:33767451DOI - Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis
Bensky MJ, Ayalon-Dangur I, Ayalon-Dangur R, et al. (2025). Frontiers in PharmacologyADOI
Community Sources
Storage
Unopened
Store cool (15–25 °C), dry, and protected from light. Methylcobalamin is light-sensitive and degrades rapidly to hydroxocobalamin upon light exposure.
Opened
Keep container tightly closed; minimize exposure to light and moisture. Do not remove tablets from packaging.
Notes
Methylcobalamin is chemically less stable than cyanocobalamin or hydroxocobalamin. Heat and UV light accelerate degradation. Opaque or dark packaging is preferred [c3].